Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tris Pharma appoints Mahdi Fawzi CSO

This article was originally published in Scrip

Executive Summary

Emerging specialty pharma company Tris Pharma, which focuses on technologies based products, has appointed Dr Mahdi Fawzi chief scientific officer and executive vice-president of R&D including regulatory affairs. Most recently Dr Fawzi served as president of global research and development at Warner Chilcott, and previously he was part of the senior leadership team at Wyeth before its acquisition by Pfizer.

Advertisement

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC016110

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel